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doubling of risk of hematologic grade ≥3 toxicity based on 
previously published NTCP parameter estimates. NTCP 
modeling well predicted toxicity using IMRT in this sample. 
Predicted toxicity using CRT lay marginally outside 95% CI 
NTCP modeling in this sample. 
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Purpose/Objective: To facilitate a prompt recommendation 
of photon vs. proton therapy a decision support system (DSS) 
is essential. This paper presents the development and 
validation of an online, three-level (dose, normal tissue 
toxicity reduction and cost-effectiveness level) proton DSS, 
and its proposed application for patients with Head and Neck 
cancer. 
Materials and Methods: Meaningful benefits were defined for 
all three levels based on expert opinions and published 
papers. For the dose comparison layer, benefit was defined 
as a plan meeting clinical acceptable organs-at-risk 
thresholds: parotid gland <26Gy, pharyngeal constrictor 
muscle superior <50Gy, supraglottis area <50Gy. For the 
toxicity reduction layer, a clinical significant grade 2+ 
toxicity reduction was set at >10% based on a published 
toxicity prediction model for xerostomia and dysphagia at 6 
and 12 months after therapy. For the cost-effectiveness 
layer, the acceptable cost for a quality-adjusted life year 
(QALY) gained was set at 80.000€ and based on a published 
Markov model. The DSS was developed with a component 
oriented design and implementation to reuse independent in-
house resources in a systematic way and implements both the 
calculations and comparisons of photons vs. protons at the 
three levels (see figure). A Head and Neck cancer patient, 
planned with both IMRT and IMPT, was used to test the DSS. 
Results: A web-based DSS was successfully developed to 
deliver layered computation and comparison services. After 
providing clinical patient information and the photon and 
proton plans, the following comparison results were 
generated (see table): (1) On a dosimetric level, proton 
therapy generated a more desirable dose distributions; (2) On 
the toxicity estimation level, proton therapy appeared more 
capable of lowering the risk of complications for xerostomia 
or swallowing dysfunction; (3) On the cost-effectiveness 
level, proton therapy was more effective although photon 
therapy was more cost-effective. 
Conclusions: This DSS is able to quantitatively compare 
photon and proton treatment options and provide multi-level 
decision support. From the limited validation, proton therapy 
demonstrates its capacity to deliver a better dose 
distribution and lower toxicity to the normal tissue in 
comparison with photon therapy. However, given the current 
acceptable payment for a QALY gained, the lower costs of 
photon therapy appears to outweigh the benefits of proton 
therapy making photons more cost-effective for this specific 
case. 
    
 
 
EP-1481   
A treatment planning study of the clinical optimality of ion 
beam therapy with different ions in presence of hypoxia 
A. Attili1, F. Torriani2, C. Mingioni2, G. Russo1, F. Dalmasso3, 
S. Giordanengo1, F. Bourhaleb4, G. Battistoni5, F. Marchetto1, 
R. Cirio3 
1Istituto Nazionale di Fisica Nucleare (INFN) Section of 
Torino, Physics, Torino, Italy  
2Politecnico di Torino, Physics, Torino, Italy  
3University of Torino, Physics, Torino, Italy  
4Internet-Simulation Evaluation Envision (I-See), Torino, Italy  
5Istituto Nazionale di Fisica Nucleare (INFN) Section of 
Milano, Physics, Milano, Italy  
 
Purpose/Objective: The reduced concentration of oxygen in 
cells (hypoxia) results in a significantly lower cell death rate 
after exposure to ionizing radiation that can lead to 
treatment failure. This oxygen effect can be expressed by 
the oxygen enhancement ratio (OER) that was found 
experimentally to be strongly related to the quality of 
radiation and, in general, to the linear energy transfer (LET). 
Studies to quantify this effect in treatment simulations have 
been pursued [Wenzl T & Wilkens, JJ (2011) Phys Med Biol, 
56; Scifoni E, et al. (2013) Phys Med Biol, 58; Bassler N, et 
al. (2014) Acta Oncol 53]. However, systematic studies to 
evaluate the impact of hypoxia in treatments with beam of 
different ion species are still lacking. Furthermore, the 
radiobiological models used to quantify the OER in these 
studies are based on the dose averaged LET estimates and do 
not explicitly distinguish among varying ion species and 
fractionation schemes. In this work a new model to predict 
the OER taking into account the specificity of the different 
ions, tissues and fractionation schemes was implemented to 
quantify the clinical outcomes of treatments with beams of 
different ion species via an intercomparison of treatment 
plans for a set of clinical cases. 
Materials and Methods: A novel model, based on the 
microdosimetric effect model [Hawkins RB (2003) Rad Res, 
160], to predict the OER was implemented. The model was 
benchmarked with in-vitro data, V79 and HSG cells in aerobic 
and hypoxic conditions, irradiated with different ions 
[Furusawa Y, et al. (2000) Rad Res, 154]. The benchmarked 
model was then included in the simulation of treatment for a 
set of 12 clinical cases (head and neck and prostate cancer) 
using p, Li, He, C and O ion beams. The plans were evaluated 
using a treatment planning system (TPS) that is able to 
evaluate the LET spectra at a voxel level for primary and 
secondary particles. The expected treatment optimality as a 
function of oxygen partial pressure, HTV size, dose per 
fraction and primary ion type, was quantified in terms of 
Tumor Control Probability (TCP) and Normal Tissue 
Complication Probability (NTCP). 
Results: The modelled OERs were found to be dependent on 
both LET and ion charge, showing also a decreasing OER for 
increasing dose per fraction with a slope that depends on the 
LET. These behaviours were found to have a good agreement 
with the experimental OER assays. The treatment simulations 
shows a substantial OER dependence by dose per fraction and 
an increase in TCP by increasing the ion charge and dose per 
fraction (e.g. up to 40% variation from p to O). However, high 
NTCP in normal tissue for high-LET radiation was also 
observed. 
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Conclusions: A novel modeling of the OER that explicitly 
includes the dependence on ion type and dose per fraction 
was implemented. The model was successfully included in a 
TPS to evaluate the impact of hypoxia with different ion 
species. 
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Purpose/Objective: An anthropomorphic phantom was built 
using LEGO Mindstorms to simulate breathing and tumors 
motion in lung district. By 4-Dimensional Computed 
Tomography (4DCT) and simulation of asynchronous motion of 
tumor and rib cage we can predict changes, due to patient's 
breathing phases, to improve accuracy of Stereotactic Body 
Radiation Therapy and motion spatial estimation.  
Materials and Methods: In our robot, human chest is 
simulated by an 8 ribs apparatus. Mechanical gears allow 
synchronous/independent motion of each rib with different 
angular velocity. 2 artificial tumor masses, with a 4 degree of 
freedom motion, are located inside the thoracic cavity. 
Robot is driven by intelligent brick LINUX OS CPU, LABView 
programmable. The phantom has pediatric dimensions 
(≈30x24x24 cm3); gears and robotic parts, made ??of plastic 
material, avoid artifacts during CT acquisition. Through 4DCT 
a real-time signal is obtained by optical surface tracking 
system (VisionRT). Patient’s breathing phases are acquired 
instantaneously by InfraRed/UltraSound eyes. Quasar 
phantom allows correlation between physiological and 
robotically surrogated signal. To understand internal-external 
motion correlation, tumor center of mass is individuated by 
4DCT images and followed during respiration. 
Results: A 4D function obtained and simulated by the 
anthropomorphic phantom during a new 4DCT study 
quantifies the degree of divergence due to internal dynamics 
of organ deformation. Sinusoidal signals (6, 10, 12, 15 and 17 
Breaths per Minute-BPM) were used to evaluate and 
commissioning phantom. Pearson correlation coefficient 
returned a strong similarity between Quasar and LEGO 
phantom, showing an R fitting 0.94÷0.90 for all signals. 
Validated on above theoretical/ad hoc waveform, the 
phantom was tested in clinical condition. Breaths and CT 
study of 6 patients were randomly selected from a sample of 
107 patients. A jitter low-pass filter was applied, to smooth 
discontinuous signals, with a threshold of 0.20÷0.30 Hz 
before observation. Analysis of real signals returned an R 
value 0.89÷0.92. In patients with a respiratory stasis between 
inspiration and expiration <1 s some criticalities occur.  
 
 
Figure (1.) The LEGO Mindstorms phantom; (2.) 4DCT study 
with maximum inspirum (orange) and expirium (blue); (3.) 
Real breath comparison (up) and difference (down). 
Conclusions: A biomechanical system shaping a realistic 
model for external/internal motion correlation was realized 
and validated for sinusoidal inputs. Due to intrinsic 
irregularities in patients, mechanical reproducibility becomes 
more complex for pseudo-periodic human breaths. Anyway, R 
remains very strong, at least for patients without abnormal 
respiratory stasis. Future research with TLD and ion chamber 
installed inside tumors and ribs models will allow evaluating 
impact of respiratory irregularities in dosimetric measures. 
Our 4D LEGO phantom can predict tumor position and 
intrafraction organs motion, with the aim of increasing 
accuracy in real-time treatments. 
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Purpose/Objective: To propose and validate a novel 
segmentation and point-matching enhanced efficient 
deformable image registration (DIR) algorithm (named 
SPEED) to facilitate dose accumulation between treatment 
fractions of high-dose-rate (HDR) gynecological 
brachytherapy. 
Materials and Methods: In SPEED, segmentation and point 
matching steps are performed before DIR to remove the 
applicator region (AR, including the packing gauze) and to 
account for the AR deformation between fractional HDR CT 
images. Specifically, in the segmentation step, the 
incremented foreground and background point sets are 
generated by region growing on a density map involving the 
